Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
AnaptysBio, Inc. (ANAB) had Free Cash Flow of $-78.39M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$76.32M |
|
$15.11M |
|
-- |
|
$76.32M |
|
$41.62M |
|
$34.70M |
|
$-19.59M |
|
$15.11M |
|
$15.11M |
|
$15.11M |
|
$15.11M |
|
$15.11M |
|
$15.11M |
|
$34.70M |
|
$34.18M |
|
27.83M |
|
29.02M |
|
$0.54 |
|
$0.52 |
|
| Balance Sheet Financials | |
$330.65M |
|
$1.50M |
|
$22.45M |
|
$353.10M |
|
$38.10M |
|
-- |
|
$344.41M |
|
$382.51M |
|
$-29.42M |
|
$-29.42M |
|
$-29.42M |
|
27.57M |
|
| Cash Flow Statement Financials | |
$-78.30M |
|
$154.53M |
|
$-89.48M |
|
$123.08M |
|
$109.83M |
|
$-13.25M |
|
$27.57M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.68 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
45.47% |
|
45.47% |
|
-- |
|
19.80% |
|
19.80% |
|
|
Free Cash Flow |
$-78.39M |
-- |
|
-- |
|
-- |
|
0.22 |
|
-- |
|
1.01 |
|
89.25 |
|
-51.38% |
|
-51.38% |
|
4.28% |
|
-51.38% |
|
$-1.07 |
|
$-2.70 |
|
$-2.70 |
|